research Acute and Chronic Telogen Effluvium
Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.
Search
forProducts matching "kintor kx-826"
Tracking 3 products like 791 KINTOR 0.5% KX-826 DHT Blocker Hair Regrowth Spray for Men & Women 60ml, 792 KINTOR 0.9% KX-826 DHT Blocker for Men & Women Hair Growth,Hair Growth Products Spray 60ml Pro and 793 KX-826 DHT Blocker Hair Thickening Growth Products，Plant-Based Extract Essence Anti-Hair Loss Solution from by companies like Amazon. View all 3 products »
Sort by
Research
270-300 / 1000+ results 
research Telogen Effluvium: Potential causes in Iraq
Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.
research [XANTHOTRICHIA (YELLOWING OF THE HAIR) DUE TO MINOXIDIL TREATMENT].
Minoxidil can cause hair to turn yellow.
research UJI AKTIVITAS PERTUMBUHAN RAMBUT KOMBINASI EKSTRAK ETANOL DAUN PANDAN WANGI (Pandanus amaryllifolius Roxb.) DAN DAUN LIDAH MERTUA (Sansevieria trifasciata Prain.)
The 3:2 combination of pandanus and sansevieria leaf extracts promotes the best hair growth.
research UJI AKTIVITAS PERTUMBUHAN RAMBUT KOMBINASI EKSTRAK ETANOL DAUN PANDAN WANGI (Pandanus amaryllifolius Roxb.) DAN DAUN LIDAH MERTUA (Sansevieria trifasciata Prain.)
The 3:2 combination of pandanus and sansevieria extracts promotes the best hair growth.
research Hair Transplant
research Telogen Effluvium
Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.
research Hair Loss Myths.
Many hair loss myths lack strong evidence, but some treatments are proven to work.
research Acute and Chronic Telogen Effluvium
Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.
research Topical agents for hair growth promotion: what is out there?
Minoxidil is the only approved cream for hair loss, but new treatments are being looked into.
research By the way, doctor. I don't hear nearly as much about hair loss in women as in men. But I'm 65 and have watched my hair thin considerably over the past five or six years. Is there anything I can do about it? What about Rogaine?
research [Treatment of androgenic alopecia with topical minoxidil].
Minoxidil, a topical solution, was found to slow balding in most cases and increase hair density in some, but only a few saw significant cosmetic improvement.
research [A critical review of the results of clinical experimentation with topical minoxidil 2%].
Topical minoxidil 2% improves hair growth in about 30% of users.
research Serum Ferritin Levels amongst Individuals with Androgenetic Alopecia in Ile-Ife, Nigeria.
People with early onset hair loss (Androgenetic Alopecia) in Ile-Ife, Nigeria, have significantly lower iron levels compared to those with adult-onset hair loss.
research Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.
Mesotherapy is more effective and preferred for female hair loss than topical minoxidil.
research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.
research Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.
research Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.
research Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.
research Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.
research Androgens/Androgen Receptor in the Management of Skin Diseases
Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.
research Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
GT20029 helps regrow hair in men with hair loss and is well-tolerated.
research Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.
research Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.
research Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.
research Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
Patients were highly satisfied with shared medical appointments for hair loss treatment.
research Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.
research Connexin 26 (GJB2) mutations in keratitis–ichthyosis–deafness syndrome presenting with squamous cell carcinoma
Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.
research The RpoS Gatekeeper in Borrelia burgdorferi: An Invariant Regulatory Scheme That Promotes Spirochete Persistence in Reservoir Hosts and Niche Diversity
RpoS helps Borrelia burgdorferi survive in hosts and adapt to different environments.
research Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.